![]() |
|
|
Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853
3To whom correspondence should be addressed. E-mail: rsp3{at}cornell.edu.
Human lung type II cell derived A549 epithelial cancer cells and HepG2 hepatocytes constitutively express cytochrome P4504F2, a P450 we previously identified as a tocopherol-
-hydroxylase. To determine if A549 cells would metabolize tocochromanols via the
-hydroxylase pathway, we compared the metabolism of tocopherols (
-,
-,
-TOH) and tocotrienols (
-,
-,
-T3) in these 2 cell lines. Cultures were incubated with
-,
-, or
-TOH, or the analogous T3s, and synthesis of their metabolites quantitated by GC-MS. A549 cells metabolized all tocochromanols 23 times more extensively than HepG2 cells (P < 0.001) except
-TOH, a difference not related to cell uptake of substrate but rather was reflective of greater microsomal TOH-
-hydroxylase enzyme activity. Notably, 9'-carboxychromanols were the major metabolites of all
- and
-TOHs and T3s in A549 cultures, whereas 3'- and 5'-carboxychromanols predominated in HepG2 cultures. Accumulation of 9'-carboxychromanols in A549 cultures was due to their inefficient conversion to 7'-carboxychromanols relative to HepG2 cells. Sesamin inhibited tocochromanol metabolism in both cells types, and neither cell type exhibited evidence of alternative (sesamin-insensitive) pathways of metabolism. TOH-
-hydroxylase activity was undetectable in rat primary lung type II cells, suggesting that expression of activity was associated with transformation of normal type II cells to cancer cells. Long-chain carboxychromanol metabolites of
-TOH and other forms of vitamin E can be biosynthesized in A549 cultures for assessment of their biological activity, including their potential inhibition of synthesis of inflammatory mediators.
KEY WORDS: tocopherols tocotrienols metabolism
-oxidation A549 HepG2
This article has been cited by other articles:
![]() |
Q. Jiang, H. Freiser, K. V. Wood, and X. Yin Identification and quantitation of novel vitamin E metabolites, sulfated long-chain carboxychromanols, in human A549 cells and in rats J. Lipid Res., May 1, 2007; 48(5): 1221 - 1230. [Abstract] [Full Text] [PDF] |
||||